Efficacy of AB1010 in Patients With Systemic Indolent Mastocytosis

Update Il y a 4 ans
Reference: NCT00831974

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This is a 12 weeks study aimed at assessing the safety and efficacy of 2 doses of AB1010 in patients suffering from indolent systemic mastocytosis with handicap.


Inclusion criteria

  • mastocytosis

Links